Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Rhone-Poulenc Overseas Limited Announces Redemption of All Outstanding Cumulative Guaranteed Preference Shares, Series A NEW YORK, Oct. 15...
Aventis Ships 30 Million Doses of Influenza Vaccine to Health-Care Providers Pre-Booked Customers Received Partial or Full Influenza Vaccine Order...
Advisory Panel Recommends FDA Licensure of Aventis' Menactra(TM) Vaccine for Protection Against Meningococcal Disease - First Candidate...
Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21...
The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/...
Coley Pharmaceutical Group Receives Payment From Aventis for Clinical Milestone in Collaboration on Allergic Respiratory Diseases WELLESLEY...
FDA Approves Taxotere(R) for the Treatment of Women with Early Stage Breast Cancer Earlier use of Taxotere(R) shown to significantly improve...
Aventis Submits Application for FDA Licensure of ADACEL(TM) Vaccine for Prevention of Tetanus, Diphtheria and Pertussis in Adolescents...
Ventiv Health Announces Sales and Marketing Agreement with Aventis Contract Calls for Over 450 Sales Representatives Focused on Primary Care...
FDA Approves Sculptra(TM) (Injectable Poly-L-Lactic Acid) BERWYN, Penn., Aug. 3 /PRNewswire/ -- Dermik Laboratories, the US dermatology arm of...
Aventis Reports Second-Quarter and First-Half Results for 2004 All figures refer to 2004 Group vs. 2003 Core unless otherwise stated STRASBOURG...
Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent BRIDGEWATER, N.J., July 27 /PRNewswire-FirstCall/ -- Aventis...
New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes SYNERGY, A to Z and a Systematic Overview of...
Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 23 /PRNewswire-FirstCall/ -- On June 22, 2004, the Autorite...
Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend PARIS, June 14 /PRNewswire-FirstCall/...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관